1. Home
  2. KOD vs NAGE Comparison

KOD vs NAGE Comparison

Compare KOD & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOD
  • NAGE
  • Stock Information
  • Founded
  • KOD 2009
  • NAGE 1999
  • Country
  • KOD United States
  • NAGE United States
  • Employees
  • KOD N/A
  • NAGE N/A
  • Industry
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • NAGE Medicinal Chemicals and Botanical Products
  • Sector
  • KOD Health Care
  • NAGE Health Care
  • Exchange
  • KOD Nasdaq
  • NAGE Nasdaq
  • Market Cap
  • KOD 795.5M
  • NAGE 766.4M
  • IPO Year
  • KOD 2018
  • NAGE N/A
  • Fundamental
  • Price
  • KOD $14.05
  • NAGE $7.29
  • Analyst Decision
  • KOD Buy
  • NAGE Strong Buy
  • Analyst Count
  • KOD 6
  • NAGE 3
  • Target Price
  • KOD $14.33
  • NAGE $17.00
  • AVG Volume (30 Days)
  • KOD 1.0M
  • NAGE 1.2M
  • Earning Date
  • KOD 11-13-2025
  • NAGE 10-30-2025
  • Dividend Yield
  • KOD N/A
  • NAGE N/A
  • EPS Growth
  • KOD N/A
  • NAGE N/A
  • EPS
  • KOD N/A
  • NAGE 0.22
  • Revenue
  • KOD N/A
  • NAGE $116,303,000.00
  • Revenue This Year
  • KOD N/A
  • NAGE $28.91
  • Revenue Next Year
  • KOD N/A
  • NAGE $20.89
  • P/E Ratio
  • KOD N/A
  • NAGE $33.36
  • Revenue Growth
  • KOD N/A
  • NAGE 35.90
  • 52 Week Low
  • KOD $1.92
  • NAGE $3.18
  • 52 Week High
  • KOD $19.39
  • NAGE $14.69
  • Technical
  • Relative Strength Index (RSI)
  • KOD 56.85
  • NAGE 31.13
  • Support Level
  • KOD $13.91
  • NAGE $7.00
  • Resistance Level
  • KOD $17.12
  • NAGE $7.70
  • Average True Range (ATR)
  • KOD 2.04
  • NAGE 0.55
  • MACD
  • KOD -0.13
  • NAGE -0.26
  • Stochastic Oscillator
  • KOD 46.80
  • NAGE 11.62

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: